ALK and neuroblastoma: Few recurrent genetic events have been linked to neuroblastoma including tumour-specific amplification of the MYCN oncogene or mutations in the genes coding for anaplastic-lymphoma kinase (ALK) and the alpha thalassemia/mental retardation syndrome X-linked (ATRX) gene [3, 4].